Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 major insurers draw lines in the sand for pricey PCSK9 coverage
2 major insurers draw lines in the sand for pricey PCSK9 coverage
2 major insurers draw lines in the sand for pricey PCSK9 coverage
Submitted by
admin
on September 2, 2015 - 12:34pm
Source:
BioPharma Dive
News Tags:
PCSK9 inhibitors
insurers
Regeneron
Sanofi
Amgen
Praluent
Repatha
Headline:
2 major insurers draw lines in the sand for pricey PCSK9 coverage
Do Not Allow Advertisers to Use My Personal information
